SOD1 and relapsing-remitting multiple sclerosis: Higher levels of SOD-1 were detected in the CSF of RRMS patients compared with HC, suggesting an impaired SOD-1 secretion and augmenting ROS that could have a role in neuroimmune regulatory responses and in the pathogenesis of MS [30].